Systems level analysis of B-cell development identifies BDNF as a driver for human B lymphopoiesis

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

B-cell aplasia impairs the immune response to cancer, infections and vaccines. However, no B-cell accelerator is available in the clinic to date. Here, we utilized a system biology approach to discover drivers for B lymphopoiesis in the human Bone Marrow (BM). By integrating scRNA-seq data analyses with intercellular communication mapping, we created an initial list of putative drivers emanating from the BM microenvironment and interacting with nascent B lymphocytes. We further intersected our findings with clinical B-cell depletion studies and developmental conditions pointing at age-impaired B lymphopoiesis. These funneling procedures enabled identification of putative top drivers on which we performed progenitor BM cells scRNA-seq stimulation assays, demonstrating their ability to upregulate immune developmental pathways within early B-cells. Finally, we succesfully validated BDNF, a neurotrophin, as a B-cell accelerator in in-vitro culture. Our systems-biology methodology paves the way towards identification of additional human hematopoiesis drivers and immune recovery and functionality.

Article activity feed